United States· US:54312-019_43fa588f-3f99-7492-e063-6294a90a5954
VITACILINA NEOMYCIN SULFATE FIRST AID ANTIBIOTIC
A neomycin product containing neomycin sulfate, registered in United States by Compania Internacional de Comercio, S.A.P.I de C.V.. The same ATC class is registered in 6 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Neomycin is registered in 6 of 19 countries.
Countries holding a registration under ATC D06AX04 (neomycin), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 3 of them publish a price we can compare per daily dose
Neomycin · ATC D06AX04
6 / 19 countries
- Finlandprice
- Germany
- Ireland
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NEOMYCIN SULFATE
- Manufacturer
- Compania Internacional de Comercio, S.A.P.I de C.V.
- Country
- United States (US)
- ATC code
- D06AX04
- ATC class
- Neomycin
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1154312019311 TUBE in 1 CARTON (54312-019-31) / 28 g in 1 TUBE
- ndc1154312019351 TUBE in 1 CARTON (54312-019-35) / 14 g in 1 TUBE
- ndc1154312-019-31
- ndc1154312-019-35
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
19 interactions on record for neomycin.
Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Neomycin · interactions on record
19 records
- 19 moderate
Most severe, free to view
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- StreptomycinJ01GA01moderate
- TobramycinJ01GB01moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Neomycin in 5 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCicatrin creamGlaxoSmithKline UK Ltd
- BelgiumPanotileZambon
- GermanyMyacyneMaxmedic Pharma Gmbh.
- PolandNeomycinum JelfaBausch+Lomb Ireland Ltd.
- CanadaNEOPRO 325CAN-VET ANIMAL HEALTH SUPPLIES LTD.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Germany · Myacyne, Neomycinsulfat Smartpractice Europe
- Spain · Neomicina
- Poland · Neomycinum, Neomycinum Tzf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e1bca365-3caa-480d-b1d3-0782dae4fac4 GET /v1/drugs/e1bca365-3caa-480d-b1d3-0782dae4fac4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "3.5",
"substance": "NEOMYCIN SULFATE",
"productndc": "54312-019",
"dosage_form": "OINTMENT",
"dea_schedule": null,
"strength_unit": "mg/g",
"application_number": "M004",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about neomycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.